Manufacturer record
Max Relief Health Care: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Max Relief Health Care (Himachal Pradesh) were declared Not of Standard Quality in August 2021. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TP-0421907, Favimax - 400 (Favipiravir Tablets 400 mg) (exp Mar 2023). CDL Kolkata (CDSCO lab) found it not of standard quality: Identification & Assay. Listed in the August 2021 alert.
Records by type
2 records linked to Max Relief Health Care in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Favimax - 400 (Favipiravir Tablets 400 mg) | Batch TP-0421907Mfg Apr 2021 · Exp Mar 2023 | Identification & AssayAssay | CDL KolkataCDSCO lab | Aug 2021 |
| Favimax - 400 (Favipiravir Tablets 400 mg) | Batch TP-0421903Mfg Apr 2021 · Exp Mar 2023 | Identification & AssayAssay | CDL KolkataCDSCO lab | Aug 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.